These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 14527774)

  • 1. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.
    Hooton TM
    Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():65-72. PubMed ID: 14527774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current management strategies for community-acquired urinary tract infection.
    Hooton TM
    Infect Dis Clin North Am; 2003 Jun; 17(2):303-32. PubMed ID: 12848472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.
    Garrison J; Hooton TM
    Expert Opin Pharmacother; 2001 Aug; 2(8):1227-37. PubMed ID: 11584990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.
    McKinnell JA; Stollenwerk NS; Jung CW; Miller LG
    Mayo Clin Proc; 2011 Jun; 86(6):480-8. PubMed ID: 21576512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
    Gupta K; Hooton TM; Stamm WE
    Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
    Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
    Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing antibiotic resistance.
    Gupta K
    Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comeback of trimethoprim in France.
    Caron F; Wehrle V; Etienne M
    Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of uncomplicated urinary tract infection.
    Hooton TM; Stamm WE
    Infect Dis Clin North Am; 1997 Sep; 11(3):551-81. PubMed ID: 9378923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapy of acute uncomplicated cystitis.
    Yamamoto S; Higuchi Y; Nojima M
    Int J Urol; 2010 May; 17(5):450-6. PubMed ID: 20337730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary tract infections and antibiotic resistance].
    Malinverni R
    Ther Umsch; 2002 Jan; 59(1):31-5. PubMed ID: 11851044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of urinary tract infections in the outpatient setting: a review.
    Grigoryan L; Trautner BW; Gupta K
    JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
    Colgan R; Johnson JR; Kuskowski M; Gupta K
    Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
    Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.